| Salwa Sami Abdelmaged Abdelhamid younis | Laboratory induced praziquantel resistant Schistosoma mansoni: Proteomic analysis and a trial to overcome the resistance by the use of nanotechnology | 2018 |
| Fadwa Mostafa Kamel Abdelrazek arafa | In vitro effect of a novel protease inhibitor cocktail on Toxoplasma gondii tachyzoites | 2018 |
| Sara Ahmed Abdelsalam Mohamedmostafa | Drug repurposing, combination therapy and nanotechnology: a novel multiple approach for effective treatment of experimental schistosomiasis mansoni | 2020 |
| Nehal Nassef Ismail Hezema | Effect of VAM2-2 and VAM2-2 loaded chitosan nanoparticles in treatment of experimental toxoplasmosis. | 2021 |
| Eman Attia Elmorsy Hassan | Schistosoma mansoni egg-derived extracellular vesicles: a promising immunizing approach against murine schistosomiasis | 2021 |
| Hoda Adel Rashed Mohamed | Effect of alginate nanoparticles on the immunogenicity of excretory secretary antigens in murine toxoplasmosis | 2021 |
| Hala Elsayed Diab Basiouny | Nano-encapsulated antioxidants: melatonin and retinoic acid as natural mucosal adjuvants for intranasal immunization against chronic experimental toxoplasmosis | 2023 |
| Nahla Fouad Elsakhawy | Anti-neoplastic activity of Toxoplasma gondii antigen on mcf-7 human breast cancer cell line and ehrlich solid carcinoma model | 2022 |
